Back to Dashboard
S-1784Senate2025-05-15Health

MAPS Act

YourVoice.Now Summary

Transparency & AccountabilityCorporate Benefits

The government would map and report on where essential medicines come from — patients would see no direct change.

Transparency & Accountability

Public list of essential medicines — updated at least every 2 years

The health secretary would have to publish the list of drugs the country cannot run short of, and refresh it at least every 2 years. The first refresh would be due 180 days after the law takes effect.

Public report on drug supply-chain risks — due within one year

A study would name which essential drugs lean on a risky foreign supplier for more than half their production. The full report would go to congressional committees and the national intelligence director first, and a public version would follow within one year.

Reporting of the military's China-sourced drugs — every 180 days

Twice a year the Defense Department would give Congress a list of every drug it bought that was made in China, or made with Chinese ingredients. The requirement would be new and would repeat every 180 days.

Corporate Benefits

Protection of drugmakers' shared data — security measures required

The health secretary would have to put strong computer security around the shared data. The point is to keep plant locations and output figures from leaking or being seen by the wrong people.

Drugmakers' legal shield on confidential data — agencies could share it

A federal law bars officials from passing along a company's confidential business information. The bill would say that law is not broken when agencies swap supply-chain data such as plant locations, output figures, and inspection records.

More about this bill

You would not see a change at the drugstore. Instead, the government would map where the country's most important medicines come from. Then it would report what it finds. The federal health secretary would keep a public list of essential medicines. The list would cover drugs needed in a chemical, biological, radiological, or nuclear emergency. It would also cover drugs at high risk of running short. Drugs that patients with long-term illness depend on would be on it, as would drugs the military calls critical. The list would be updated at least every 2 years. The first update would be due 180 days after the law takes effect. A study of those drugs' supply chains would follow. A public version of it would be due within one year. To do the mapping, agencies could trade drug companies' private business records with each other. Every 180 days, the Pentagon would tell Congress which drugs it bought from China, or made with Chinese ingredients. Nothing in it would require anyone to fix a shortage or build a plant in the U.S.

Congressional Summary

Mapping America’s Pharmaceutical Supply Act or the MAPS ActThis bill requires the Food and Drug Administration (FDA) to continually update its essential medicines list and identify risks and vulnerabilities in the associated supply chains.In 2020, in response to an executive order, the FDA published a list of essential medicines deemed medically necessary to have available at all times. The bill requires the FDA to update and maintain this list to include drugs and ingredients (1) related to responding to public health threats and emergency incidents, (2) of greatest priority for providing health care and at high risk of shortage, (3) the shortage of which would adversely affect patients with chronic conditions, and (4) that the Department of Defense (DOD) determines to be critical for military preparedness. The FDA must update the list at least every two years.Also, the bill requires the FDA to conduct a risk assessment of the supply chains for drugs and ingredients on the list and annually report its findings to Congress. The assessment must include information about key manufacturing materials, drugs with primarily foreign suppliers, manufacturing capacity, relevant public health and national security risks, and risk mitigation strategies.Additionally, the Department of Health and Human Services, in coordination with other agencies, must map and monitor relevant supply chains to identify vulnerabilities and provide an annual status report to Congress.Finally, DOD must report to Congress every 180 days on the drugs DOD purchased that were manufactured in or sourced from China.

Legislative Subjects

Computer security and identity theftCongressional oversightData collection, sharing, protectionGovernment information and archivesManufacturingPrescription drugsStrategic materials and reservesSupply chain

Details

Congress
119th
Chamber
Senate
Status
summarized
Action
Introduced in Senate
Action Date
2025-05-15
Date Added
2026-09-03
Source
Congress.gov →

Like reading a bill in plain English?

We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.

By default, we'll only email you once — when the app launches. Unless you opt in below, you won't receive anything else. We don't share or sell your email.